MIT research shows positive results of skin patch for cancer treatment
By Nikita Chaurasia  Date: 2019-08-26

MIT research shows positive results of skin patch for cancer treatment
  • The skin patch designed, demonstrated positive results in an experiment on mice and human skin samples.
  • The MIT researchers designed the patch to fight melanoma cancer.

Researchers at the Massachusetts Institute of Technology reportedly announced successful results of a skin patch developed to offer cancer treatment in mice & human skin samples at the American Chemical Society conference in California, San Diego.

Apparently, the researchers at the MIT designed the patch to fight melanoma, a fatal but treatable skin cancer. For the uninitiated, Melanoma is subjected to be caused by an extreme exposure to UV rays from the sun or other sources. It has been claimed that the patch is less than a centimeter long and covered with a gluey film, which allows it to be applied and detached from the skin within a minute.

As per trusted reports, the researchers of the organization used the patch to deliver a toxin in healthy mice and later compared the immune response to other treatment methods used to vaccinate against the flu and measles. The results of the skin patch presented a robust antibody response along with a strong immune response in human skin.

The lead author of the study and HOD of Chemical Engineering, MIT, Dr. Paula Hammond reportedly stated that the organization’s recently designed patch technology can be used to offer vaccines to fight against various infectious diseases. Additionally, the researchers are pleased by the possibility of the patch to win against melanoma cancer.

The patch is embedded with microneedles, developed through a layer-by-layer coating process. This provides the advantage over syringes for its painless, easy to administer and reduced infection risk characteristics.

The researchers claimed that the patch treatment produced over 9 times the level of infection-fighting antibodies while comparing to the intramuscular injections. Additionally, it also produced over 160 times the level of antibodies compared to subcutaneous injections.

Speculation has it that the research was aided by the U.S. Department of Defense along with the Koch Institute for Integrative Cancer Research at MIT and Singapore-MIT Alliance for Research and Technology.

Source credit: https://www.cnbc.com/2019/08/25/new-skin-patch-to-deliver-cancer-medicine-shows-promise-in-mice-mit-scientists-say.html

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Tesla CEO Elon Musk reveals plans to build ventilators for COVID-19
Tesla CEO Elon Musk reveals plans to build ventilators for COVID-19
By Nikita Chaurasia

U.S. auto giant Tesla, Inc.’s CEO, Elon Musk has recently made headlines when he announced that his company is planning to develop ventilators for COVID-19 patients. The move comes after the United States government’s latest appeal for do...

Google News launches Project Oasis to support local entrepreneurs
Google News launches Project Oasis to support local entrepreneurs
By Nikita Chaurasia

Google News has apparently launched Project Oasis in partnership with the University of North Carolina, Table Stakes co-founder Doug Smith, and LION Publishers. The partnership is aimed at helping the founders and aspiring founders of digital ne...

Pfizer collaborates with BioNTech to develop coronavirus vaccine
Pfizer collaborates with BioNTech to develop coronavirus vaccine
By Nikita Chaurasia

Increasing numbers of coronavirus cases worldwide have prompted researchers to develop a potential vaccine candidate to treat COVID-19 patients. Pfizer Inc., one of the leading American pharmaceutical companies, has reportedly collaborated with BioNT...

Amplitude completes debut acquisition with ClearBrain buyout
Amplitude completes debut acquisition with ClearBrain buyout
By Nikita Chaurasia

Amplitude, a comprehensive product intelligence company, announced that it has acquired the software company ClearBrain to accelerate big product bets. The acquisition will enable customers of the company to estimate about the revenue growth driving ...

Vodafone launches its 5G network in limited parts of Australia
Vodafone launches its 5G network in limited parts of Australia
By Nikita Chaurasia

Vodafone has finally stepped up in the 5G race as it goes live with its 5G services in some parts of Australia. According to reports, the service will be available in select parts of Sydney. However, unlike other Australian telecoms, Vodafone will no...